Recent development of nanomedicine for the treatment of inflammatory diseases
M Higaki - Inflammation and Regeneration, 2009 - jstage.jst.go.jp
… Thus we need to develop a drug delivery system in particular nanocarriers, with enhanced
localization to the target site and sustained drug release. We have engineered nanoparticles …
localization to the target site and sustained drug release. We have engineered nanoparticles …
Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease
… considerations in terms of developing disease-directed drug delivery systems, then focuses
on mechanisms and strategies of current oral nano-drug delivery systems, including size-, …
on mechanisms and strategies of current oral nano-drug delivery systems, including size-, …
Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
S Mohajeri, S Moayedi, S Mohajeri… - Frontiers in …, 2022 - frontiersin.org
… of a drug, biomaterials-based drug delivery systems can be … design of biomaterials-based
drug delivery systems for efficient … using biomaterials-based drug delivery systems, which can …
drug delivery systems for efficient … using biomaterials-based drug delivery systems, which can …
Targeting inflammation to improve tumor drug delivery
… tumor drug delivery is imperative. We present here the main obstacles to drug delivery to
the … Furthermore, the use of anti-inflammatory agents is proposed as a promising alternative …
the … Furthermore, the use of anti-inflammatory agents is proposed as a promising alternative …
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
… Areas covered: This review addresses the main barriers for colon-specific drug delivery from
… Expert opinion: Oral colon-specific drug delivery represents a possible approach toward …
… Expert opinion: Oral colon-specific drug delivery represents a possible approach toward …
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
D Li, M Yang, H Xu, M Zhu, Y Zhang, C Tian… - Journal of Materials …, 2022 - pubs.rsc.org
… Colonic drug delivery relies on changes in gastrointestinal physiology, microbial changes,
and digestive enzymes in inflammatory bowel disease. Patients with IBD have significantly …
and digestive enzymes in inflammatory bowel disease. Patients with IBD have significantly …
Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases
… delivery approach with reduced … delivery and absorption of drug through intestinal mucosa
while reducing systemic availability by promotion of first pass metabolism. The drug delivery …
while reducing systemic availability by promotion of first pass metabolism. The drug delivery …
Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease
Z Zeng, X He, C Li, S Lin, H Chen, L Liu, X Feng - Biomaterials, 2021 - Elsevier
… , we believe that the strategies we described here may provide a convenient and powerful
platform for the treatment of other inflammatory diseases. … Emerging frontiers in drug delivery …
platform for the treatment of other inflammatory diseases. … Emerging frontiers in drug delivery …
Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system
HJ Kim, C Neophytou - Archives of pharmacal Research, 2009 - Springer
… (IBD) including Ulcerative Colitis (UC) and Crohn Disease (CD) commencing immune-…
colonic drug delivery has gained increased importance not just for the treatment of local diseases …
colonic drug delivery has gained increased importance not just for the treatment of local diseases …
Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis
… -based drug delivery systems (DDS) may be promising tools for targeted delivery to the colon,
… This review highlights general considerations and limitations for oral drug delivery to the …
… This review highlights general considerations and limitations for oral drug delivery to the …